Mytelase enhances the transmission of nerve impulses from nerve fibers to muscles. In myasthenia gravis , this transmission is weakened because the receptors ( receptors ) for the neurotransmitter acetylcholine are damaged. Mytelase reduces the breakdown of acetylcholine and the concentration increases, which improves the transmission of nerve impulses.
Alphabetical list of medicines staring with letter M
Mysimba contains 2 active substances: naltrexone hydrochloride and bupropion hydrochloride and is used in adults with overweight or obesity to lose weight along with a calorie-reduced diet and physical activity. The drug acts on areas of the brain that are involved in controlling food intake and energy consumption.
Mysildecard contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
Myozyme is used to treat adults, children and adolescents of all ages where the diagnosis of Pompe disease is established.
This medicine is for diagnostic purposes only, as an aid in disease diagnosis. Myoview is a radioactive medicine. It is given before the examination and allows a special camera to see inside a part of your body.
MYLOTARG contains the active substance gemtuzumabozogamicin, an anticancer medicine, which consists of a monoclonal antibody bound to a substance which is intended to kill cancer cells. This substance is delivered to the cancer cells by the monoclonal antibody . A monoclonal antibody is a protein that recognizes certain cancer cells.
Myleran contains the active substance busulfan which belongs to a group of medicines called cytostatics . Busulfan reduces the number of new blood cells that bone marrow produces, which reduces the symptoms of the disease.
The active substance in the tablets is modafinil. Modafinil can be taken by adults suffering from narcolepsy to help stay awake. Narcolepsy is a condition that causes pronounced drowsiness during the day and a tendency to suddenly fall asleep in inappropriate situations (sleep attacks).
Mycophenolic Acid Accord contains a substance called mycophenolic acid. This belongs to a group of medicines called Immunosuppressive medicines.
500 mg film-coated tablets mycophenolate mofetil
Mycophenolate mofetil Accord 250 mg capsules contain mycophenolate mofetil. It belongs to a group of medicines called "immunosuppressants".
Myfortic contains a substance called mycophenolic acid and belongs to a group of medicines called immunosuppressants.
Myfenax belongs to a group of medicines called immunosuppressants.
Mydriasert is an ophthalmic product, which means that it is only intended for the treatment of eyes.
Mydriacyl 0.5% eye drops , solution contains the active substance tropicamide.
0.2 mg / ml + 3.1 mg / ml + 10 mg / ml solution for injectiontropicamide / phenylephrine hydrochloride / lidocaine hydrochloride What Mydrane is and what it is used for What Mydrane is This medicine is a solution that is injected into the eye. It contains three active substances: tropicamide, which belongs to a group […]
Mycophenolate mofetil Sandoz contains mycophenolate mofetil. It belongs to a group of medicines called "immunosuppressants".
Mycophenolate mofetil Accord is used to prevent the body from rejecting a transplanted kidney, heart or liver. Mycophenolate mofetil is used with other medicines such as cyclosporine and corticosteroids .
Mycamine contains the active substance micafungin. Mycamine is an antifungal medicine and is used to treat infections caused by fungal cells. Mycamine is used to treat fungal infections caused by fungal or yeast cells called Candida . Mycamine is effective in treating systemic fungal infections (fungal infections inside the body). Mycamine interferes with the production of a component in the cell wall of the fungus. An intact cell wall is necessary for the fungus to continue to live and grow. Mycamine creates defects in the cell wall of the fungus and thus makes it impossible for the fungus to live and
3 mg powder for solution for injection metreleptin
MVASI contains the active ingredient bevacizumab, which is a humanized monoclonal antibody (a type of protein normally produced by the immune system to help protect the body against infections and cancer). Bevacizumab selectively binds to a protein called VEGF ( human vascular endothelial growth factor), which is found inside the body's blood and lymph vessels. VEGF protein causes blood vessels to grow in tumors and these blood vessels supply the tumor with nutrients and oxygen. When bevacizumab is bound to VEGF, the growth of the tumor is prevented by the growth of the blood vessels that supply the tumorone with